SPOTLIGHT: WellPoint execs involved in reform controversies leave

Two WellPoint executives who were involved in controversies that buffeted the insurer during the health overhaul debate are leaving, the Wall Street Journal reports. Cynthia Miller, the company's top actuary, and Bradley Fluegel, its chief of strategy, will depart from the company. Miller was called to defend WellPoint’s large rate increases before Congress. When those premiums were found to be built partially on mathematical errors, the insurer withdrew and recalculated them. Fluegel oversaw government relations during a period in which the company sparred with the Obama administration. After the attention to the rate increases, WellPoint faced accusations that it targets women with breast cancer for rescission of their health policies, which the company denied. Article

Suggested Articles

Blues plans have reportedly agreed to a $2.7 billion antitrust settlement.

Premera Blue Cross will pay $6.9 million to HHS over a data breach six years ago that exposed 10 million people's health information.

HHS and the FDA finalized a rule that enables states to seek approval to re-import certain drugs from Canada for a cheaper price.